A microbead-enhanced electrochemical platform for β-amyloid peptide (1–42) detection

Bibliographic Details
Title: A microbead-enhanced electrochemical platform for β-amyloid peptide (1–42) detection
Authors: Claudia do Amaral Razzino, Lívia Flório Sgobbi, Juliana Cancino-Bernardi, Angelica Maria Mazuera Zapata, Clara Cardoso Costa, Valtencir Zucolotto, Lucia Vieira, Anderson Oliveira Lobo
Source: Frontiers in Sensors, Vol 5 (2024)
Publisher Information: Frontiers Media S.A., 2024.
Publication Year: 2024
Collection: LCC:Biotechnology
Subject Terms: screen-printed electrode, magnetic beads, amperometric immunosensor, amperometric sandwich immunoassay, β-amyloid peptide (1–42), Biotechnology, TP248.13-248.65
More Details: Alzheimer’s disease is the most prevalent form of dementia and is primarily characterized by the accumulation of β-amyloid and phosphorylated tau proteins in the brain, along with the degeneration of nerve cells, which leads to impairment of various cognitive functions. A significant biomarker of Alzheimer’s disease is the decreased level of soluble β-amyloid peptide (1–42) (Aβ1-42) in cerebrospinal fluid (CSF), as pathology progresses when CSF-Aβ1-42 levels drop below 192 pg mL−1. In this study, we developed an amperometric immunosensor based on magnetic beads as the platform for constructing the immunosensor. Monoclonal antibodies are immobilized on the MBs, enabling selective detection of Aβ1-42. The detection antibody is conjugated with the enzyme horseradish peroxidase, which, in the presence of H2O2 and hydroquinone, catalyzes the decomposition of H2O2 and the oxidation of hydroquinone to p-quinone, generating an electric current measured at a potential of −200 mV (vs. the Ag pseudo-reference electrode) using screen-printed carbon electrodes. The amperometric sandwich-type immunosensor demonstrates a linear response in the concentration range of 10 to 10,000 pg mL−1, with a detection limit of 7.4 pg mL−1, exhibiting excellent selectivity against the assessed interferents. These findings suggest the potential application of this immunosensor in the early diagnosis of Alzheimer’s disease, offering a sensitive and specific tool for clinical analysis. Despite its high performance, further studies are required to validate its robustness and applicability in complex clinical samples.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2673-5067
Relation: https://www.frontiersin.org/articles/10.3389/fsens.2024.1508810/full; https://doaj.org/toc/2673-5067
DOI: 10.3389/fsens.2024.1508810
Access URL: https://doaj.org/article/10496aea2ffd4f54ab271536c89d6c29
Accession Number: edsdoj.10496aea2ffd4f54ab271536c89d6c29
Database: Directory of Open Access Journals
More Details
ISSN:26735067
DOI:10.3389/fsens.2024.1508810
Published in:Frontiers in Sensors
Language:English